HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $299,000 | +30.6% | 2,694 | +39.8% | 0.01% | +16.7% |
| Q4 2020 | $229,000 | +6.0% | 1,927 | +12.6% | 0.01% | 0.0% |
| Q4 2019 | $216,000 | 0.0% | 1,711 | 0.0% | 0.01% | -53.8% |
| Q3 2019 | $216,000 | -43.3% | 1,711 | -46.0% | 0.03% | -38.1% |
| Q2 2019 | $381,000 | +38.0% | 3,170 | +0.3% | 0.04% | +35.5% |
| Q1 2019 | $276,000 | +20.0% | 3,160 | +37.7% | 0.03% | +10.7% |
| Q4 2018 | $230,000 | – | 2,295 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |